In 2024, the Company determined that additional U.S. deferred income tax assets were more likely than not to be realized ...

Reports Q4 revenue $939M, consensus $954.17M. The company said, “Net income attributable to Visteon (VC) was $122 million, or $4.37 per diluted ...

The Hackett Group, Inc. (NASDAQ: HCKT), an IP platform-based, Gen AI strategic consulting and executive advisory firm that enables Digital World Class® performance, today announced its financial ...

I would like to welcome everyone to The Chemours Company fourth-quarter 2024 results conference call. [Operator instructions] I would like to remind everyone that this conference call is being ...

We think this is prudent, considering current interest-rate and office market headwinds. Interest coverage (EBITDA/interest expense) of 4.3 times as of Dec. 31, 2024 is reasonable, but it is likely to ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2024.

The proposal is estimated to save $50 billion in spending over 10 years. Kate is a CPA with experience in audit and ...

Arteris will host a conference call today on February 18, 2025 to review its fourth quarter and full year 2024 financial results and to discuss its financial outlook. A live webcast will also be ...

Declares Dividend Increase for 69th Consecutive YearProvides 2025 Outlook Fourth Quarter 2024 Highlights Sales of $5.8 billionDiluted EPS of $0.96Adjusted Diluted EPS of $1.61Full-Year 2024 Highlights ...

The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and ...

Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025.